{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:36:19Z","timestamp":1761917779300},"reference-count":33,"publisher":"American Diabetes Association","issue":"Supplement_2","license":[{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"vor","delay-in-days":3781,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,5,1]]},"DOI":"10.2337\/dc11-s207","type":"journal-article","created":{"date-parts":[[2011,4,27]],"date-time":"2011-04-27T21:30:32Z","timestamp":1303939832000},"page":"S128-S131","update-policy":"http:\/\/dx.doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":57,"title":["Is Hyperglycemia a Cardiovascular Risk Factor?"],"prefix":"10.2337","volume":"34","author":[{"given":"Frank","family":"Pistrosch","sequence":"first","affiliation":[{"name":"Center for Clinical Studies, Endocrinology and Metabolic Research, GWT, Technical University Dresden, Dresden, Germany"},{"name":"University Hospital \u201cCarl Gustav Carus,\u201d Department of Internal Medicine III, Technical University Dresden, Dresden, Germany"}]},{"given":"Andrea","family":"Natali","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Pisa, Pisa, Italy"}]},{"given":"Markolf","family":"Hanefeld","sequence":"additional","affiliation":[{"name":"Center for Clinical Studies, Endocrinology and Metabolic Research, GWT, Technical University Dresden, Dresden, Germany"}]}],"member":"1167","published-online":{"date-parts":[[2011,4,22]]},"reference":[{"key":"2022031219000445400_B1","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1001\/jama.290.14.1884","article-title":"Lifetime risk for diabetes mellitus in the United States","volume":"290","author":"Narayan","year":"2003","journal-title":"JAMA"},{"key":"2022031219000445400_B2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/diacare.16.2.434","article-title":"Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial","volume":"16","author":"Stamler","year":"1993","journal-title":"Diabetes Care"},{"key":"2022031219000445400_B3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.322.7277.15","article-title":"Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)","volume":"322","author":"Khaw","year":"2001","journal-title":"BMJ"},{"key":"2022031219000445400_B4","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa0908359","article-title":"Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults","volume":"362","author":"Selvin","year":"2010","journal-title":"N Engl J Med"},{"key":"2022031219000445400_B5","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2337\/dc07-2124","article-title":"Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects","volume":"31","author":"Juutilainen","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031219000445400_B6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/0003-4819-141-6-200409210-00007","article-title":"Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus","volume":"141","author":"Selvin","year":"2004","journal-title":"Ann Intern Med"},{"key":"2022031219000445400_B7","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/S0140-6736(02)09089-X","article-title":"Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study","volume":"359","author":"Norhammar","year":"2002","journal-title":"Lancet"},{"key":"2022031219000445400_B8","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.2337\/diacare.27.12.2836","article-title":"Blood glucose and risk of cardiovascular disease in the Asia Pacific region","volume":"27","author":"Lawes","year":"2004","journal-title":"Diabetes Care"},{"key":"2022031219000445400_B9","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","article-title":"Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes","volume":"295","author":"Monnier","year":"2006","journal-title":"JAMA"},{"key":"2022031219000445400_B10","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.2337\/diacare.23.12.1830","article-title":"Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level","volume":"23","author":"Temelkova-Kurktschiev","year":"2000","journal-title":"Diabetes Care"},{"key":"2022031219000445400_B11","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"2022031219000445400_B12","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"2022031219000445400_B13","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1084\/jem.20081188","article-title":"Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia","volume":"205","author":"El-Osta","year":"2008","journal-title":"J Exp Med"},{"key":"2022031219000445400_B14","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nature04634","article-title":"Reactive oxygen species have a causal role in multiple forms of insulin resistance","volume":"440","author":"Houstis","year":"2006","journal-title":"Nature"},{"key":"2022031219000445400_B15","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1172\/JCI11235","article-title":"Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site","volume":"108","author":"Du","year":"2001","journal-title":"J Clin Invest"},{"key":"2022031219000445400_B16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis: an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"2022031219000445400_B17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0735-1097(99)00168-0","article-title":"Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery","volume":"34","author":"Kawano","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"2022031219000445400_B18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/s-0028-1103276","article-title":"Effects of the alpha glucosidase inhibitor acarbose on endothelial function after a mixed meal in newly diagnosed type 2 diabetes","volume":"41","author":"Pistrosch","year":"2009","journal-title":"Horm Metab Res"},{"key":"2022031219000445400_B19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2337\/diacare.29.01.06.dc05-0955","article-title":"Effects of different insulin regimes on postprandial myocardial perfusion defects in type 2 diabetic patients","volume":"29","author":"Scognamiglio","year":"2006","journal-title":"Diabetes Care"},{"key":"2022031219000445400_B20","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031219000445400_B21","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031219000445400_B22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"2022031219000445400_B23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1464-5491.2009.02915.x","article-title":"Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early type 2 diabetes","volume":"27","author":"Hanefeld","year":"2010","journal-title":"Diabet Med"},{"key":"2022031219000445400_B24","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2337\/dc09-1278","article-title":"Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial","volume":"33","author":"Riddle","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031219000445400_B25","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2337\/dc09-1471","article-title":"Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial","volume":"33","author":"Calles-Escand\u00f3n","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031219000445400_B26","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031219000445400_B27","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0140-6736(09)60697-8","article-title":"Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials","volume":"373","author":"Ray","year":"2009","journal-title":"Lancet"},{"key":"2022031219000445400_B28","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1002\/(SICI)1096-9136(199708)14:3+<S6::AID-DIA438>3.0.CO;2-H","article-title":"The postprandial state and the risk of atherosclerosis","volume":"14","author":"Hanefeld","year":"1997","journal-title":"Diabet Med"},{"key":"2022031219000445400_B29","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"2022031219000445400_B30","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"2022031219000445400_B31","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"2022031219000445400_B32","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"2022031219000445400_B33","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/34\/Supplement_2\/S128\/609862\/s128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/34\/Supplement_2\/S128\/609862\/s128.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T20:11:54Z","timestamp":1647115914000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/34\/Supplement_2\/S128\/28303\/Is-Hyperglycemia-a-Cardiovascular-Risk-Factor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,22]]},"references-count":33,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2011,4,22]]},"published-print":{"date-parts":[[2011,5,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc11-s207","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,22]]}}}